Commission invites views on forthcoming human tissue product regulations
This article was originally published in Clinica
Executive Summary
Could the competencies of the European Medicines Evaluations Agency be extended to cover the evaluation and approval of healthcare products containing human materials? That is one of the key questions that is being raised by the European Commission in its web-based consultation on the need for a community legal framework on "human tissue engineered products", a market worth some E100bn (US99bn)a year.